MedPro Rx, Inc. Announces 2011 "Education Is Power" Scholarship Program

RALEIGH, NC, March 20, 2011 (Press-News.org) Nancy McFarlane, president of MedPro Rx, Inc. (http://www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses who need clotting factor, IVIg and other medication, has announced that applications are now open for its "Education Is Power" scholarship program. The annual program is open to U.S. residents who are living with a bleeding disorder such as hemophilia or von Willebrand Disease; entering or attending a community college, junior college, four-year college, university or vocational school; and active in their community. Application forms are available on MedPro Rx's website and must be postmarked by May 1, 2011 to be eligible for consideration. A minimum of 20 scholarships will be awarded this year ranging in value from $500 to $2,500. Since 2006, MedPro Rx has awarded more than $250,000 in academic scholarships.

QUOTES:
"MedPro Rx is committed to supporting the futures of our country's brightest students through our 'Education is Power' scholarship," said McFarlane. "Receiving an education helps students prepare for their future, leading to jobs that provide health insurance and preventing the financial burden that can be associated with having a chronic illness."

"Every year we receive many excellent scholarship applications and hear students' inspiring stories," said Kathy Robinette-Stoneberg, scholarship coordinator for MedPro Rx. "We are looking forward to helping many students this year as they pursue their higher education goals."

DETAILS:
- For more information about MedPro Rx's "Education is Power" program or its pharmacy services, visit http://www.medprorx.com or call (866) 528-4963.

- Hemophilia is a rare, hereditary disorder that causes excessive bleeding to occur spontaneously or after injury. The bleeding may be external or internal into joints, muscles, the abdominal cavity, the brain and other organs. Hemophilia affects approximately 20,000 people nationwide, crossing all racial and socioeconomic groups, with a higher incidence among males.

- Von Willebrand Disease is caused by a deficiency or defect of a clotting protein, and it affects approximately 1-2 percent of the United States population. Unlike Hemophilia, vWD occurs equally among males and females and is more likely to cause nosebleeds and bleeding under the skin than into the joints.

NEW MEDIA CONTENT:
"Education is Power" Scholarship Podcast:
http://www.medprorx.com/scholarship.html

MedPro Rx Facebook Page:
http://www.facebook.com/pages/MedPro-Rx/187320711288991?v=info

MedPro Rx Blog
http://medprorx.blogspot.com/

ABOUT MEDPRO RX, INC.:
MedPro Rx, Inc. is a specialty infusion pharmacy, serving clients who require clotting factor, IVIg and other medications for complex chronic conditions. Established in Raleigh, N.C., in 2002, MedPro Rx's team has more than 250 years of combined pharmacy, nursing and management experience. MedPro Rx, an Accreditation Commission for Health Care, Inc. provider (ACHC), emphasizes treatments for individuals with autoimmune neuromuscular disorders as well as rare bleeding disorders, such as hemophilia and von Willebrand Disease. The pharmacy has received numerous awards for its success and was most recently named one of the top fastest-growing, privately held companies in the Triangle by Triangle Business Journal. For more information about MedPro Rx, call (888) 571-3100 or visit http://www.medprorx.com/.

Brittney Storm
MMI Public Relations
(919) 233-6600
brittney@mmipublicrelations.com
http://twitter.com/MMIPR
http://www.mmipublicrelations.com